ID | 61237 |
フルテキストURL | |
著者 |
Afify, Said M.
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
ORCID
Calle, Anna Sanchez
Division of Molecular and Cellular Medicine, National Cancer Center Research Institute
Hassan, Ghmkin
Laboratory of Nano-Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University
ORCID
publons
Kumon, Kazuki
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
Nawara, Hend M.
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
Zahra, Maram H.
Laboratory of Nano-Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University
Mansour, Hager M.
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
Khayrani, Apriliana Cahya
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
Alam, Md Jahangir
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
Du, Juan
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
Seno, Akimasa
Okayama University Research Laboratory of Stem Cell Engineering in Detroit, IBio, Wayne State University
ORCID
Kaken ID
publons
researchmap
Iwasaki, Yoshiaki
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Okayama University
ORCID
Kaken ID
publons
researchmap
Seno, Masaharu
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University
ORCID
Kaken ID
publons
researchmap
|
抄録 | Background
Liver cancer is the second most common cause of cancer-related death. Every type of tumours including liver cancer contains cancer stem cells (CSCs). To date, the molecular mechanism regulating the development of liver CSCs remains unknown.
Methods
In this study, we tried to generate a new model of liver CSCs by converting mouse induced pluripotent stem cells (miPSCs) with hepatocellular carcinoma (HCC) cell line Huh7 cells conditioned medium (CM). miPSCs treated with CM were injected into the liver of BALB/c nude mice. The developed tumours were then excised and analysed.
Results
The primary cultured cells from the malignant tumour possessed self-renewal capacity, differentiation potential and tumorigenicity in vivo, which were found rich in liver cancer-associated markers as well as CSC markers.
Conclusions
We established a model of liver CSCs converting from miPS and showed different stages of stemness during conversion process. Our CSC model will be important to assess the molecular mechanisms necessary to develop liver CSCs and could help in defeating liver cancer.
|
キーワード | Cancer models
Cancer stem cells
|
発行日 | 2020-03-17
|
出版物タイトル |
British Journal of Cancer
|
巻 | 122巻
|
号 | 9号
|
出版者 | Springer Nature
|
開始ページ | 1378
|
終了ページ | 1390
|
ISSN | 0007-0920
|
NCID | AA00574355
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © Authors
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.1038/s41416-020-0792-z
|
ライセンス | http://creativecommons. org/licenses/by/4.0/
|